167 related articles for article (PubMed ID: 2451756)
1. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.
Hsu KH; Lonberg-Holm K; Alstein B; Crowell RL
J Virol; 1988 May; 62(5):1647-52. PubMed ID: 2451756
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody that inhibits infection of HeLa and rhabdomyosarcoma cells by selected enteroviruses through receptor blockade.
Crowell RL; Field AK; Schleif WA; Long WL; Colonno RJ; Mapoles JE; Emini EA
J Virol; 1986 Feb; 57(2):438-45. PubMed ID: 3003376
[TBL] [Abstract][Full Text] [Related]
3. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells.
Reagan KJ; Goldberg B; Crowell RL
J Virol; 1984 Mar; 49(3):635-40. PubMed ID: 6321753
[TBL] [Abstract][Full Text] [Related]
4. Attempts to purify a second cellular receptor for a coxsackievirus B3 variant, CB3-RD from HeLa cells.
Mohanty JG; Crowell RL
Virus Res; 1993 Sep; 29(3):305-20. PubMed ID: 8237113
[TBL] [Abstract][Full Text] [Related]
5. Purification of a HeLa cell receptor protein for group B coxsackieviruses.
Mapoles JE; Krah DL; Crowell RL
J Virol; 1985 Sep; 55(3):560-6. PubMed ID: 2991580
[TBL] [Abstract][Full Text] [Related]
6. Clinical coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors.
Bergelson JM; Modlin JF; Wieland-Alter W; Cunningham JA; Crowell RL; Finberg RW
J Infect Dis; 1997 Mar; 175(3):697-700. PubMed ID: 9041347
[TBL] [Abstract][Full Text] [Related]
7. Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.
Pan J; Narayanan B; Shah S; Yoder JD; Cifuente JO; Hafenstein S; Bergelson JM
J Virol; 2011 Jul; 85(14):7436-43. PubMed ID: 21561916
[TBL] [Abstract][Full Text] [Related]
8. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
[TBL] [Abstract][Full Text] [Related]
9. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a monoclonal antibody that blocks attachment of the major group of human rhinoviruses.
Colonno RJ; Callahan PL; Long WJ
J Virol; 1986 Jan; 57(1):7-12. PubMed ID: 3001366
[TBL] [Abstract][Full Text] [Related]
11. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
[TBL] [Abstract][Full Text] [Related]
12. Receptor proteins on newborn Balb/c mouse brain cells for coxsackievirus B3 are immunologically distinct from those on HeLa cells.
Xu R; Mohanty JG; Crowell RL
Virus Res; 1995 Mar; 35(3):323-40. PubMed ID: 7785319
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies that inhibit attachment of group B coxsackieviruses.
Campbell BA; Cords CE
J Virol; 1983 Nov; 48(2):561-4. PubMed ID: 6312109
[TBL] [Abstract][Full Text] [Related]
14. Enterovirus IgM detection: specificity of mu-antibody-capture radioimmunoassays using virions and procapsids of Coxsackie B virus.
Frisk G; Nilsson E; Ehrnst A; Diderholm H
J Virol Methods; 1989; 24(1-2):191-202. PubMed ID: 2547815
[TBL] [Abstract][Full Text] [Related]
15. Identification of the integrin VLA-2 as a receptor for echovirus 1.
Bergelson JM; Shepley MP; Chan BM; Hemler ME; Finberg RW
Science; 1992 Mar; 255(5052):1718-20. PubMed ID: 1553561
[TBL] [Abstract][Full Text] [Related]
16. A whole cell immunization-derived monoclonal antibody that protects cells from coxsackievirus A9 infection binds to both cell surface and virions.
Roivainen M; Alakulppi N; Ylipaasto P; Eskelinen M; Paananen A; Airaksinen A; Hovi T
J Virol Methods; 2005 Dec; 130(1-2):108-16. PubMed ID: 16055201
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein.
Compton SR; Stephensen CB; Snyder SW; Weismiller DG; Holmes KV
J Virol; 1992 Dec; 66(12):7420-8. PubMed ID: 1279203
[TBL] [Abstract][Full Text] [Related]
18. The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range.
Schickli JH; Zelus BD; Wentworth DE; Sawicki SG; Holmes KV
J Virol; 1997 Dec; 71(12):9499-507. PubMed ID: 9371612
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis.
Kishimoto C; Kurokawa M; Ochiai H
J Mol Cell Cardiol; 2002 Sep; 34(9):1227-38. PubMed ID: 12392896
[TBL] [Abstract][Full Text] [Related]
20. Transformation of a human poliovirus receptor gene into mouse cells.
Mendelsohn C; Johnson B; Lionetti KA; Nobis P; Wimmer E; Racaniello VR
Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7845-9. PubMed ID: 3020560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
